Generic placeholder image

Recent Patents on Anti-Infective Drug Discovery

Author(s): Jalil Kardan-Yamchi, Mohaddese Mahboubi, Hossein Kazemian, Gholamreza Hamzelou and Mohammad M. Feizabadi*

DOI: 10.2174/1574891X14666191028113321

Cite As
The Chemical Composition and Anti-mycobacterial Activities of Trachyspermum copticum and Pelargonium graveolens Essential Oils

Page: [68 - 74] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: Microbial resistance to antibiotics and their adverse effects related to these antibiotics are a matter of global public health in the 21th century. The emergence of drug-resistant strains, has gained the interest of the scientists to discover new antimicrobial agents from the essential oil of medicinal plants.

Methods: Anti-mycobacterial effects of Trachyspermum copticum and Pelargonium graveolens essential oils were determined against multi-drug resistant clinical strains of Mycobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium fortuitum and standard strain of Mycobacterium tuberculosis H37Rv by a Broth micro-dilution method. Pelargonium graveolens plant named Narmada was discovered by Kulkarni R.N et al. (Patent ID, USPP12425P2) and a formulation comprising thymol obtained from Trachyspermum is useful in the treatment of drug-resistant bacterial infections (Patent ID, US6824795B2). The chemical composition of hydro-distilled essential oils was determined by GC and GC-MS.

Results: Minimum Inhibitory Concentration (MIC) values for T. copticum essential oil against tested isolates were ranged from 19.5 µg/mL to 78 µg/mL. The least minimum inhibitory concentration of P. graveolens extract against M. Kansasii and MDR-TB was 78 µg/ml.

Conclusion: The results of the present research introduced T. copticum and P. graveolens essential oils as a remarkable natural anti-mycobacterial agent, but more pharmacological studies are required to evaluate their efficacy in animal models.

Keywords: Trachyspermum copticum, Pelargonium graveolens, essential oil, antimycobacterial activity, Mycobacterium tuberculosis, chemical composition.

Graphical Abstract

[1]
Khan R, Zakir M, Afaq SH, Latif A, Khan AU. Activity of solvent extracts of Prosopis spicigera, Zingiber officinale and Trachyspermum ammi against multidrug resistant bacterial and fungal strains. J Infect Dev Ctries 2010; 4(5): 292-300.
[http://dx.doi.org/10.3855/jidc.621] [PMID: 20539061]
[2]
Narayanan AS, Raja SS, Ponmurugan K, Kandekar SC, Natarajaseenivasan K, Maripandi A, et al. Antibacterial activity of selected medicinal plants against multiple antibiotic resistant uropathogens: a study from Kolli Hills, Tamil Nadu, India. Benef Microbes 2011; 2(3): 235-43.
[http://dx.doi.org/10.3920/BM2010.0033] [PMID: 21986363]
[3]
Vitali LA, Beghelli D, Nya PCB, Bistoni O, Cappellacci L, Damiano S, et al. Diverse biological effects of the essential oil from Iranian Trachyspermum ammi. Arab J Chem 2016; 9(6): 775-86.
[http://dx.doi.org/10.1016/j.arabjc.2015.06.002]
[4]
Mahboubi M, Kazempour N. Chemical composition and antimicrobial activity of Satureja hortensis and Trachyspermum copticum essential oil. Iran J Microbiol 2011; 3(4): 194-200.
[PMID: 22530088]
[5]
Seow YX, Yeo CR, Chung HL, Yuk HG. Plant essential oils as active antimicrobial agents. Crit Rev Food Sci Nutr 2014; 54(5): 625-44.
[http://dx.doi.org/10.1080/10408398.2011.599504] [PMID: 24261536]
[6]
Ghannadi A, Bagherinejad M, Abedi D, Jalali M, Absalan B, Sadeghi N. Antibacterial activity and composition of essential oils from Pelargonium graveolens L’Her and Vitex agnus-castus L. Iran J Microbiol 2012; 4(4): 171-6.
[PMID: 23205247]
[7]
Kulkarni RN, Ravindra NR, Ramesh SI, et al. Pelargonium graveolens plant named ‘Narmada. USPP12425P2 2002.
[8]
Singh KSP, Suchi S, Kumar SA, et al. Formulation comprising thymol useful in the treatment of drug resistant bacterial infections US20020322731 2004.
[9]
Bairwa R, Sodha RS, Rajawat BS. Trachyspermum ammi. Pharmacogn Rev 2012; 6(11): 56-60.
[http://dx.doi.org/10.4103/0973-7847.95871] [PMID: 22654405]
[10]
Soni R, Sharma G, Jasuja ND. Essential oil yield pattern and antibacterial and insecticidal activities of Trachyspermum ammi and Myristica fragrans. Scientifica 2016; 2016
[11]
Moein MR, Zomorodian K, Pakshir K, Yavari F, Motamedi M, Zarshenas MM. Trachyspermum ammi (L.) sprague: chemical composition of essential oil and antimicrobial activities of respective fractions. J Evid Based Complementary Altern Med 2015; 20(1): 50-6.
[http://dx.doi.org/10.1177/2156587214553302] [PMID: 25305209]
[12]
Khan R, Zakir M, Khanam Z, Shakil S, Khan AU. Novel compound from Trachyspermum ammi (Ajowan caraway) seeds with antibiofilm and antiadherence activities against Streptococcus mutans: a potential chemotherapeutic agent against dental caries. J Appl Microbiol 2010; 109(6): 2151-9.
[http://dx.doi.org/10.1111/j.1365-2672.2010.04847.x] [PMID: 20846336]
[13]
Kaur GJ, Arora DS. Antibacterial and phytochemical screening of Anethum graveolens, Foeniculum vulgare and Trachyspermum ammi. BMC Complement Altern Med 2009; 9(1): 30.
[http://dx.doi.org/10.1186/1472-6882-9-30] [PMID: 19656417]
[14]
Mobaiyen H, Nasarollah Pour M, Elmi F. Phytochemical composition and antibacterial activity of Trachyspermum copticum L. essential oil, East Azerbaijan, Iran. J Med Microbiol Infect Dis 2015; 3(3): 71-4.
[15]
Gilani AH, Jabeen Q, Ghayur MN, Janbaz KH, Akhtar MS. Studies on the antihypertensive, antispasmodic, bronchodilator and hepatoprotective activities of the Carum copticum seed extract. J Ethnopharmacol 2005; 98(1-2): 127-35.
[http://dx.doi.org/10.1016/j.jep.2005.01.017] [PMID: 15763373]
[16]
Ahsan SK, Shah AH, Tanira MOM, Ahmad MS, Tario M, Ageel AM. Studies on some herbal drugs used against kidney stones in Saudi folk medicine. Fitoterapia 1990; 61: 435-8.
[17]
Thangam C, Dhananjayan R. Antiinflammatory potential of the seeds of Carum copticum Linn. Indian J Pharmacol 2003; 35: 388-91.
[18]
Boskabady MH, Jandaghi P, Kiani S, Hasanzadeh L. Antitussive effect of Carum copticum in Guinea pigs. J Ethnopharmacol 2005; 97(1): 79-82.
[http://dx.doi.org/10.1016/j.jep.2004.10.016] [PMID: 15652279]
[19]
Ramaswamy S, Sengottuvelu S, Haja SS, et al. Gastroprotective activity of ethanolic extract of Trachyspermum ammi fruit. Int J Pharm Biosci 2010; 1: 1-15.
[20]
Mahboubi M, Feizabadi MM, Khamechian T, Kazempour N, Razavi Zadeh M, Sasani F. The effect of Oliveria decumbens and Pelargonium graveolens on healing of infected skin wounds in mice. World J Plast Surg 2016; 5(3): 259-64.
[PMID: 27853689]
[21]
Lavasanijou MR, Sohrabi HR, Karimi M, Ashjazade MA, Salajeghe M, Farzineejadizadeh H. Wound healing effects of Quercus brantii and Pelargonium graveolens extracts in male wistar rats. Wounds 2016; 28(10): 369-75.
[PMID: 27768575]
[22]
Giongo JL, de Almeida Vaucher R, Fausto VP, Quatrin PM, Lopes LQS, Santos RCV, et al. Anti-Candida activity assessment of Pelargonium graveolens oil free and nanoemulsion in biofilm formation in hospital medical supplies. Microb Pathog 2016; 100: 170-8.
[http://dx.doi.org/10.1016/j.micpath.2016.08.013] [PMID: 27544324]
[23]
Ben Hsouna A, Hamdi N. Phytochemical composition and antimicrobial activities of the essential oils and organic extracts from Pelargonium graveolens growing in Tunisia. Lipids Health Dis 2012; 11(1): 167.
[http://dx.doi.org/10.1186/1476-511X-11-167] [PMID: 23216669]
[24]
Boukhris M, Simmonds MS, Sayadi S, Bouaziz M. Chemical composition and biological activities of polar extracts and essential oil of rose-scented geranium, Pelargonium graveolens. Phytother Res 2013; 27(8): 1206-13.
[http://dx.doi.org/10.1002/ptr.4853] [PMID: 23027699]
[25]
Bigos M, Wasiela M, Kalemba D, Sienkiewicz M. Antimicrobial activity of geranium oil against clinical strains of Staphylococcus aureus. Molecules 2012; 17(9): 10276-91.
[http://dx.doi.org/10.3390/molecules170910276] [PMID: 22929626]
[26]
Adams RP. Identification of essential oil components by gas chromatography/mass spectroscopy. J Am Soc Mass Spectrom 1997; 8(6): 671-2.
[27]
WHO. Global Working Group on Antituberculosis Drug Resistance Surveillance Guidelines for Surveillance of Drug Resistance in Tuberculosis. 1997. Available from https://stoptb.org/assets/documents/gdf/drugsupply/Guidelines%20for%20surveillance%20of%20drug%20resistance%20in%20TB_eng.pdf
[28]
World Health Organization. Anti-tuberculosis drug resistance in the world Fourth global report The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007 World Health Organization 2008. Availabe from: https://www.who.int/tb/publications/tb-drugresistance-fourthreport/en/
[29]
Mativandlela S, Lall N, Meyer JJM. Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC)(Geraniaceae) root extracts S Afr J Bot 2006; 72(2): 232-7.
[http://dx.doi.org/10.1016/j.sajb.2005.08.002]
[30]
Hassanshahian M, Bayat Z, Saeidi S, Shiri Y. Antimicrobial activity of Trachyspermum ammi essential oil against human bacterial. Int J Adv Biol Biomed Res 2014; 2: 18-24.
[31]
Rasooli I, Fakoor MH, Yadegarinia D, Gachkar L, Allameh A, Rezaei MB. Antimycotoxigenic characteristics of Rosmarinus officinalis and Trachyspermum copticum L. essential oils. Int J Food Microbiol 2008; 122(1-2): 135-9.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2007.11.048] [PMID: 18190993]
[32]
Malik T, Singh P, Pant S, Chauhan N, Lohani H. Potentiation of antimicrobial activity of ciprofloxacin by Pelargonium graveolens essential oil against selected uropathogens. Phytother Res 2011; 25(8): 1225-8.
[http://dx.doi.org/10.1002/ptr.3479] [PMID: 21618302]
[33]
Maham S, Fallah F, Eslami G, Shamsafar S, Radmanesh R, Pourkaveh B. The antimycobacterium activity of Menthe piperita and Menthe spicata ethanolic extract against Mycobacterium bovis in comparison with isoniazid. Iran J Clin Infect Dis 2011; 6(2): 78-81.
[34]
Igbokwe C, Lawal T, Adeniyi B. In vitro anti-mycobacteria sensitivity and kill-kinetics of Allium ascalonicum L. (whole plant) on nontuberculous mycobacteria species. Afr J Biomed Res 2014; 17(2): 93-9.
[35]
Kazemian H, Heidari H, Yamchi JK, Zandi H, Taji A, Yazdani F. In vitro anti-mycobacterial activity of three medicinal plants of Lamiaceae family. Recent Pat Antiinfect Drug Discov 2018; 13(3): 240-5.
[http://dx.doi.org/10.2174/1574891X13666180626170155] [PMID: 29952265]
[36]
Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002; 347(23): 1860-6.
[http://dx.doi.org/10.1056/NEJMcp021045] [PMID: 12466511]
[37]
Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2014; 2(4): 321-38.
[http://dx.doi.org/10.1016/S2213-2600(14)70031-1] [PMID: 24717628]
[38]
Wang M, Guan X, Chi Y, Robinson N, Liu JP. Chinese herbal medicine as adjuvant treatment to chemotherapy for multidrug-resistant tuberculosis (MDR-TB): a systematic review of randomised clinical trials. Tuberculosis (Edinb) 2015; 95(4): 364-72.
[http://dx.doi.org/10.1016/j.tube.2015.03.003] [PMID: 25861717]
[39]
van Ingen J, Boeree MJ, van Soolingen D, Mouton JW. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 2012; 15(3): 149-61.
[http://dx.doi.org/10.1016/j.drup.2012.04.001] [PMID: 22525524]
[40]
Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011; 469(7331): 483-90.
[http://dx.doi.org/10.1038/nature09657] [PMID: 21270886]
[41]
Tiberi S, Buchanan R, Caminero JA, Centis R, Arbex MA, Salazar M. The challenge of the new tuberculosis drugs. Presse Med 2017; 46(2 Pt 2): e41-51.
[http://dx.doi.org/10.1016/j.lpm.2017.01.016] [PMID: 28256383]